WO2005011566A3 - Utilisation cosmetique d’un derive de biguanide en tant qu’actif anti-vieillissement de la peau - Google Patents

Utilisation cosmetique d’un derive de biguanide en tant qu’actif anti-vieillissement de la peau Download PDF

Info

Publication number
WO2005011566A3
WO2005011566A3 PCT/FR2004/002039 FR2004002039W WO2005011566A3 WO 2005011566 A3 WO2005011566 A3 WO 2005011566A3 FR 2004002039 W FR2004002039 W FR 2004002039W WO 2005011566 A3 WO2005011566 A3 WO 2005011566A3
Authority
WO
WIPO (PCT)
Prior art keywords
skin
active substance
cosmetic use
biguanide derivative
ageing active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2004/002039
Other languages
English (en)
Other versions
WO2005011566A2 (fr
Inventor
Pierre Jean-Paul Potier
Nobumichi-Andre Sasaki
Maria Conception Achab
Gisele Franck
Joanna Bakala
Francoise Picot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMAMENS
Original Assignee
PHARMAMENS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMAMENS filed Critical PHARMAMENS
Priority to JP2006521624A priority Critical patent/JP2007500172A/ja
Priority to CA002534135A priority patent/CA2534135A1/fr
Priority to EP04786009A priority patent/EP1651171A2/fr
Publication of WO2005011566A2 publication Critical patent/WO2005011566A2/fr
Publication of WO2005011566A3 publication Critical patent/WO2005011566A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne l’utilisation cosmétique d’un dérivé de biguanide en tant qu’actif anti-vieillissement de la peau. En particulier, la metformine est appropriée à l’utilisation selon la présente invention.
PCT/FR2004/002039 2003-07-29 2004-07-29 Utilisation cosmetique d’un derive de biguanide en tant qu’actif anti-vieillissement de la peau Ceased WO2005011566A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2006521624A JP2007500172A (ja) 2003-07-29 2004-07-29 皮膚の抗老化剤としてのビグアニド誘導体の美容的使用
CA002534135A CA2534135A1 (fr) 2003-07-29 2004-07-29 Utilisation cosmetique d'un derive de biguanide en tant qu'actif anti-vieillissement de la peau
EP04786009A EP1651171A2 (fr) 2003-07-29 2004-07-29 Utilisation cosmetique d'un derive de biguanide en tant qu'actif anti-vieillissement de la peau

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0309307A FR2858227B1 (fr) 2003-07-29 2003-07-29 Utilisation cosmetique d'un derive de biguanide en tant qu'actif anti-vieillissement de la peau
FR03/09307 2003-07-29

Publications (2)

Publication Number Publication Date
WO2005011566A2 WO2005011566A2 (fr) 2005-02-10
WO2005011566A3 true WO2005011566A3 (fr) 2005-03-24

Family

ID=34043631

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2004/002039 Ceased WO2005011566A2 (fr) 2003-07-29 2004-07-29 Utilisation cosmetique d’un derive de biguanide en tant qu’actif anti-vieillissement de la peau

Country Status (5)

Country Link
EP (1) EP1651171A2 (fr)
JP (1) JP2007500172A (fr)
CA (1) CA2534135A1 (fr)
FR (1) FR2858227B1 (fr)
WO (1) WO2005011566A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2901133B1 (fr) * 2006-05-22 2013-04-26 Oreal Utilisation de modulateurs de la glycolyse comme agents anti-age
EP3291825A4 (fr) * 2015-05-05 2019-04-17 Idunn Technologies Composition anti-age comprenant un extrait de plante
CN111053700A (zh) * 2018-10-17 2020-04-24 程定超 一种二甲双胍抗衰老的护肤品
JP7633003B2 (ja) * 2019-11-29 2025-02-19 ポーラ化成工業株式会社 抗老化成分のスクリーニング方法
CN111346047B (zh) * 2020-03-12 2022-04-01 复旦大学 一种热致水凝胶二甲双胍缓释制剂及其制备方法和应用
JP2022108114A (ja) * 2021-01-12 2022-07-25 株式会社スタイルアンドバリュージャパン オートファジー誘導剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886048A (en) * 1996-07-16 1999-03-23 Fresenius Ag PHMB for the treatment of tumor disease
WO2003037356A1 (fr) * 2001-10-26 2003-05-08 Fresenius Kabi Deutschland Gmbh Composition pharmaceutique contenant un facteur de croissance et/ou une cytokine et un biguanide antiseptique

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886048A (en) * 1996-07-16 1999-03-23 Fresenius Ag PHMB for the treatment of tumor disease
WO2003037356A1 (fr) * 2001-10-26 2003-05-08 Fresenius Kabi Deutschland Gmbh Composition pharmaceutique contenant un facteur de croissance et/ou une cytokine et un biguanide antiseptique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HARBORNE L ET AL: "Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome", LANCET THE, LANCET LIMITED. LONDON, GB, vol. 361, no. 9372, 31 May 2003 (2003-05-31), pages 1894 - 1901, XP004428386, ISSN: 0140-6736 *

Also Published As

Publication number Publication date
JP2007500172A (ja) 2007-01-11
FR2858227A1 (fr) 2005-02-04
FR2858227B1 (fr) 2005-12-23
EP1651171A2 (fr) 2006-05-03
CA2534135A1 (fr) 2005-02-10
WO2005011566A2 (fr) 2005-02-10

Similar Documents

Publication Publication Date Title
WO2004035569A3 (fr) Nouveaux composes antibacteriens
WO2007110415A3 (fr) Utilisation de trimères diacétyliques et formulations cosmétiques ou thérapeutiques contenant ces composés
TWI328576B (en) Diketohydrazine derivative compound, medicament containing same as active ingredient
WO2007129270A3 (fr) Nouvelles compositions cosmétiques contenant au moins un peptide doté d'au moins un cycle aromatique immobilisé
CY1110069T1 (el) Παραγωγα πυριμιδινης πα την θεραπεια μη κανονικησαναπτυξης κυτταρου
WO2006038116A3 (fr) Agents antibacteriens
WO2005020877A3 (fr) Utilisation de biotine ou d'un derive de biotine pour eclaircir le teint et traiter les taches de vieillesse
WO2009077497A3 (fr) Azolylméthyloxiranes, utilisation de ceux-ci et agents contenant ceux-ci
WO2004014893A3 (fr) Quinolones anti-microbiens, leurs compositions et utilisation
WO2004022029A3 (fr) Compositions de soins personnels a base d'alcool ramifie
CL2007000875A1 (es) Metodo cosmetico de despigmentacion de la piel que comprendeaplicar a la piel una composicion que comprende a)0,000001-50% de un compuesto derivado de 4-hidroxifenilpiruvato y b) un vehiculo; composicion que comprende a)0,000001-50% de un compuesto derivado de 4-hidroxifenilpiruvato y b)un vehiculo cosmeticamente aceptable.
WO2009016046A3 (fr) Compositions pour bronzage sans soleil
WO2007144521A3 (fr) Composition cosmetique a usage topique comprenant du wasabi
WO2002101073A3 (fr) Composes aryl-benzimidazole presentant une activite anti-infectieuse
MXPA02011039A (es) Combinaciones de productos activos fungicidas.
WO2008003900A3 (fr) Utilisation en cosmétique d'un derivé c-glycoside en association avec de l'acide ascorbique
WO2005011566A3 (fr) Utilisation cosmetique d’un derive de biguanide en tant qu’actif anti-vieillissement de la peau
AU2003210383A1 (en) Low ph, high skin friction cosmetic creams
WO2007050348A3 (fr) Inhibiteurs du canal potassique
WO2005097787A3 (fr) Derives de benzothiazoles capables de moduler l’activite des cdk et leur utilisation comme agents anticancereux
WO2006121717A3 (fr) Compositions pour soins de la peau contenant de l'idebenone
WO2005005382A3 (fr) Composes, compositions et procedes associes
WO2008113450A3 (fr) Utilisation de dérivés de chroman-4-one
WO2011026577A3 (fr) Préparations dotées d'amines polymères non hydrosolubles pour réduire des odeurs corporelles
WO2002034210A3 (fr) Utilisation de l'association d'au moins un carotenoide et de vitamine c pour traiter les signes cutanes du vieillissement

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2534135

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2006521624

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004786009

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004786009

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004786009

Country of ref document: EP